In pancreatic cancer, VISTA may induce the immune deficiency microenvironment, and compared to a melanoma, which is sensitive to immunotherapy, the expression of VISTA is higher on CD68+ macrophages in pancreatic cancer. This evidence concerns the gene CD68 and familial pancreatic carcinoma.